Traders in Omeros Attributing Upside in Shares to Bullish Note from MLV & Co., Says Trend Higher 'Will Continue'
May 14, 2013 at 15:58 PM EDT
McNicoll Lewis Vlak & Co.'s George Zavoico issued a research note Tuesday highlighting some positive feedback from physicians on Omeros Corp.'s (NASDAQ: OMER ) OMS302 at the Association for Research in Vision and Ophthalmology. The analyst maintains a Buy rating and $14 price target on shares of Omeros. Zavoico pointed
